{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:53:41Z","timestamp":1768881221772,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,30]]},"DOI":"10.7759\/cureus.34408","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T23:30:27Z","timestamp":1675121427000},"source":"Crossref","is-referenced-by-count":3,"title":["Severe Lenalidomide-Associated Hyperbilirubinemia"],"prefix":"10.7759","author":[{"given":"Daniel T","family":"Gildea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph L","family":"Roswarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-2-36","article-title":"Mechanism of action of lenalidomide in hematological malignancies","volume":"2","author":"Kotla V","year":"2009","unstructured":"Kotla V, Goel S, Nischal S, Heuck C, Vivek K, Das B, Verma A. Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol. 2009, 2:36. 10.1186\/1756-8722-2-36","journal-title":"J Hematol Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e328302c7f4","article-title":"NF-kappaB in the pathogenesis and treatment of multiple myeloma","volume":"15","author":"Li ZW","year":"2008","unstructured":"Li ZW, Chen H, Campbell RA, Bonavida B, Berenson JR. NF-kappaB in the pathogenesis and treatment of multiple myeloma. Curr Opin Hematol. 2008, 15:391-9. 10.1097\/MOH.0b013e328302c7f4","journal-title":"Curr Opin Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1126\/science.124491","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of ikaros proteins","volume":"343","author":"Lu G","year":"2014","unstructured":"Lu G, Middleton RE, Sun H, et al.. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of ikaros proteins. Science. 2014, 343:305-9. 10.1126\/science.124491","journal-title":"Science"},{"key":"ref4","article-title":"Lenalidomide","year":"2012","unstructured":"Lenalidomide. LiverTox. Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda; 2012."},{"key":"ref5","article-title":"Roussel Uclaf Causality Assessment Method (RUCAM) in Drug Induced Liver Injury","year":"2012","unstructured":"Roussel Uclaf Causality Assessment Method (RUCAM) in Drug Induced Liver Injury. LiverTox. Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda; 2012."},{"key":"ref6","article-title":"Lenalidomide-associated hepatotoxicity - a case report and literature review","volume":"32","author":"Nojkov B","year":"2012","unstructured":"Nojkov B, Signori C, Konda A, et al.. Lenalidomide-associated hepatotoxicity - a case report and literature review. Anticancer Res. 2012, 32:4117-9.","journal-title":"Anticancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.1471","article-title":"Hyperbilirubinemia following lenalidomide administration","volume":"6","author":"Azmy V","year":"2018","unstructured":"Azmy V, Neparidze N. Hyperbilirubinemia following lenalidomide administration. Clin Case Rep. 2018, 6:875-7. 10.1002\/ccr3.1471","journal-title":"Clin Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1078155212439492","article-title":"Lenalidomide-induced elevated bilirubin","volume":"18","author":"Simondsen KA","year":"2012","unstructured":"Simondsen KA, Kolesar JM. Lenalidomide-induced elevated bilirubin. J Oncol Pharm Pract. 2012, 18:402-5. 10.1177\/1078155212439492","journal-title":"J Oncol Pharm Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000326935","article-title":"A case of drug-induced hepatitis due to lenalidomide","volume":"5","author":"Zanella MC","year":"2011","unstructured":"Zanella MC, Rubbia-Brandt L, Giostra E, Chalandon Y, Hadengue A, Spahr L. A case of drug-induced hepatitis due to lenalidomide. Case Rep Gastroenterol. 2011, 5:217-22. 10.1159\/000326935","journal-title":"Case Rep Gastroenterol"},{"key":"ref10","article-title":"Acute renal failure associated with lenalidomide treatment in multiple myeloma: a rare occurrence?","volume":"36","author":"Kreiniz N","year":"2016","unstructured":"Kreiniz N, Khateeb A, Gino-Moor S, et al.. Acute renal failure associated with lenalidomide treatment in multiple myeloma: a rare occurrence?. Anticancer Res. 2016, 36:2889-92.","journal-title":"Anticancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-097758","article-title":"Lenalidomide-induced severe hepatotoxicity","volume":"110","author":"Hussain S","year":"2007","unstructured":"Hussain S, Browne R, Chen J, Parekh S. Lenalidomide-induced severe hepatotoxicity. Blood. 2007, 110:3814. 10.1182\/blood-2007-06-097758","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1152-y","article-title":"Lenalidomide induced intrahepatic cholestasis in newly diagnosed patients of multiple myeloma","volume":"68","author":"Jena RK","year":"2012","unstructured":"Jena RK, Swain TR, Kansurkar SS, Swain M. Lenalidomide induced intrahepatic cholestasis in newly diagnosed patients of multiple myeloma. Eur J Clin Pharmacol. 2012, 68:881-4. 10.1007\/s00228-011-1152-y","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/136174-severe-lenalidomide-associated-hyperbilirubinemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:20Z","timestamp":1707508280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/136174-severe-lenalidomide-associated-hyperbilirubinemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.34408","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,30]]}}}